Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid

Asthma, remains symptomatic despite ongoing treatment with high doses of inhaled corticosteroids (ICS) in conjunction with long-acting beta-agonists (LABA), is classified as “severe” asthma. In the course of caring for those patients diagnosed with severe asthma, stepping up from ICS/LABA to more ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreher, Michael, Müller, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771741/
https://www.ncbi.nlm.nih.gov/pubmed/29256220
http://dx.doi.org/10.4046/trd.2017.0102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771741/
https://www.ncbi.nlm.nih.gov/pubmed/29256220
http://dx.doi.org/10.4046/trd.2017.0102

Ejemplares similares